Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2019-10-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于召开重大资产重组媒体说明会的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about a media briefing related to a major asset restructuring by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the date, time, location, agenda, and participants of the media briefing. The document does not contain financial statements or detailed financial analysis but rather informs about the upcoming event and how media and investors can participate. It also mentions that the company will disclose the meeting's outcome in subsequent announcements. The document length is 1955 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a media briefing for a major asset restructuring, not the restructuring report itself or a detailed financial report.
2019-10-08 Chinese
发行股份购买资产暨关联交易报告书（草案）（修订稿）
Regulatory Filings
2019-10-08 Chinese
发行股份购买资产暨关联交易报告书（草案）（修订稿）摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed report concerning a major asset acquisition and related party transaction by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes extensive disclosures about the transaction parties, background, financial data, risk disclosures, legal and regulatory compliance, and detailed explanations of the transaction structure and impact. The document references a "重大资产重组报告书" (Major Asset Restructuring Report) and includes financial figures, audit references, and legal opinions. The content is consistent with a comprehensive filing related to a significant corporate restructuring involving issuance of shares to purchase assets and related party transactions. This type of document is characteristic of a Capital/Financing Update (CAP) filing, as it details the issuance of shares to purchase assets, the restructuring, and related financing arrangements. It is not a simple announcement or a summary but a full report with substantive financial and transactional details. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-10-08 Chinese
关于深圳证券交易所重组问询函回复的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement and response to an inquiry from the Shenzhen Stock Exchange regarding a major asset restructuring involving Zhejiang Huatong Pharmaceutical Co., Ltd. It discusses the background, reasons, necessity, and pricing of a share transfer agreement, the change in actual controller of the company, and the accounting treatment of the transaction. The document includes extensive financial data, tables of shareholder changes, and references to audit and evaluation reports. It also discusses whether the transaction constitutes a same-control business combination and the preparation of pro forma financial data. The document is lengthy (15,000 characters) and contains substantive financial data and analysis related to a significant corporate restructuring and acquisition. It is not a brief announcement or a certification letter but a comprehensive disclosure related to a capital restructuring and acquisition transaction. Therefore, the document fits best into the category of Capital/Financing Update (CAP), as it provides detailed updates on the company's capital structure changes and financing arrangements related to the acquisition and share transfer.
2019-10-08 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It contains detailed declarations about the nominee's qualifications and compliance with various regulatory requirements. There is no financial data, no report of voting results, no meeting materials, and no mention of financial performance or management changes. The document is a formal announcement related to board/management information, specifically about a director nomination. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 3449 characters, which is consistent with a detailed announcement rather than a full report.
2019-09-24 Chinese
华金证券股份有限公司关于公司调整募投项目内部投资结构及投资总额的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring institution (华金证券股份有限公司) regarding the adjustment of internal investment structure and total investment amount of fundraising projects by 浙江华通医药股份有限公司. It references regulatory approvals, fundraising details, investment projects, and adjustments to investment structures. The document includes financial figures related to the use of proceeds from a convertible bond issuance and discusses compliance with regulatory requirements. It is not a full annual or interim report, nor is it a simple announcement or certification. It is a specialized audit or verification report related to fundraising and investment project adjustments, which fits the category of Audit Report / Information (AR). The document length (4778 characters) and content confirm it is a substantive report rather than a brief announcement or certification. H1 2019
2019-09-24 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.